Holdings derived from the most recent reported transactions. Not adjusted for stock splits or share-class conversions.
| Issuer | Shares | Source | Last tx | Detail |
|---|---|---|---|---|
| Werewolf Therapeutics, Inc. | 4,784,111 | reported | 04 Dec 2025 | tx 3−199,732 |
| Harpoon Therapeutics, Inc. | 3,225,510 | reported | 12 Apr 2021 | tx 4−12,796 |
| TCR2 THERAPEUTICS INC. | 0 | reported | 01 Jun 2023 | tx 1−4,158,964 |
| Date | Type | Issuer | Qty | Price | Signals |
|---|---|---|---|---|---|
| 03 Dec 2025 | SALE | Werewolf Therapeutics, Inc. | 57,225 | 0.87 USD | |
| 04 Dec 2025 | SALE | Werewolf Therapeutics, Inc. | 83,230 | 0.97 USD | |
| 02 Dec 2025 | SALE | Werewolf Therapeutics, Inc. | 59,277 | 0.89 USD | |
| 01 Jun 2023 | OTHER | TCR2 THERAPEUTICS INC. | 4,158,964 | 0.00 USD | |
| 12 Apr 2021 | SALE | Harpoon Therapeutics, Inc. | 811 | 21.52 USD | |
| 12 Apr 2021 | SALE | Harpoon Therapeutics, Inc. | 1,637 | 20.72 USD | |
| 09 Apr 2021 | SALE | Harpoon Therapeutics, Inc. | 10,300 | 23.67 USD | |
| 12 Apr 2021 | SALE | Harpoon Therapeutics, Inc. | 48 | 22.68 USD |